Media Summary: In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Register for our free featured webinar here: Read more on this story here: The US ... Learn about a new treatment option approved by the U.S. Food and Drug Administration (FDA) that may help reduce and ...
Revitalizing Pharma Collaborations The Reblozyl Case Study - Detailed Analysis & Overview
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Register for our free featured webinar here: Read more on this story here: The US ... Learn about a new treatment option approved by the U.S. Food and Drug Administration (FDA) that may help reduce and ... Maria D. Cappellini, Professor of Internal Medicine, University of Milan, Italy, presents findings from the clinical experience with ... This is the first of the series 'Drug repurposing for rare diseases' and features expert speakers sharing their experiences in the ... This lecture is part of the NIH Principles of Clinical Pharmacology Course which is an online lecture series covering the ...
Know AML is delighted to share a series of videos telling the story of Ralph Hills and Dr Gail Roboz. Ralph was diagnosed with ... Dr. Adekemi Taylor, Senior Director of Integrated Drug Development at Certara, discusses the role of modeling and simulation in ... Matthew Sherman, MD, chief medical officer at Acceleron talks about the company's lead orphan drug product in development ... How often do you open your EHR to find lab results that are slightly abnormal, but you're not sure if you need to worry about them ... In episode 11 we talk about approval of Rebloyzl for beta thalassemia, new product Brukinsa for mantle cell lymphoma, Fetroja for ...
